Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles and functions of IAV proteins in host immune evasion. | Front Immunol | 2023 | 38152399 | PubTator, text mining | PubMed |
| Epigenetic targeting of autophagy for cancer: DNA and RNA methylation. | Front Oncol | 2023 | 38148841 | PubTator, text mining | PubMed |
| Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma. | Pharmaceuticals (Basel) | 2023 | 38139762 | PubTator, text mining | PubMed |
| Stem-Cell-Derived Extracellular Vesicles: Unlocking New Possibilities for Treating Diminished Ovarian Reserve and Premature Ovarian Insufficiency. | Life (Basel) | 2023 | 38137848 | PubTator, text mining | PubMed |
| Impaired Expression of the Salvador Homolog-1 Gene Is Associated with the Development and Progression of Colorectal Cancer. | Cancers (Basel) | 2023 | 38136317 | PubTator, text mining | PubMed |
| Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies. | Cancers (Basel) | 2023 | 38136274 | PubTator, text mining | PubMed |
| Phase Separation as a Driver of Stem Cell Organization and Function during Development. | J Dev Biol | 2023 | 38132713 | PubTator, text mining | PubMed |
| Exploring Various Transfection Approaches and Their Applications in Studying the Regenerative Potential of Dental Pulp Stem Cells. | Curr Issues Mol Biol | 2023 | 38132472 | PubTator, text mining | PubMed |
| Hippo pathway in intestinal diseases: focusing on ferroptosis. | Front Cell Dev Biol | 2023 | 38130953 | PubTator, text mining | PubMed |
| Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2. | Elife | 2023 | 38126343 | PubTator, text mining | PubMed |
| CiRS-7 Enhances the Liquid-liquid Phase Separation of miRISC and Promotes DNA Damage Repair. | Nucleus | 2023 | 38105528 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review. | Cancer Med | 2023 | 38098217 | PubTator, text mining | PubMed |
| YAP-mediated trophoblast dysfunction: the common pathway underlying pregnancy complications. | Cell Commun Signal | 2023 | 38098027 | PubTator, text mining | PubMed |
| Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer. | Cell Death Dis | 2023 | 38092743 | PubTator, text mining | PubMed |
| Regulatory mechanism of macrophage polarization based on Hippo pathway. | Front Immunol | 2023 | 38090595 | PubTator, text mining | PubMed |
| A positive feedback circuit driven by m6A-modified circular RNA facilitates colorectal cancer liver metastasis. | Mol Cancer | 2023 | 38087322 | PubTator, text mining | PubMed |
| Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1/G protein subunit alpha Z axis. | World J Gastrointest Oncol | 2023 | 38077646 | PubTator, text mining | PubMed |
| Function of macrophage-derived exosomes in chronic liver disease: From pathogenesis to treatment. | World J Hepatol | 2023 | 38075004 | PubTator, text mining | PubMed |
| PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway. | Sci Rep | 2023 | 38071381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=13